Detalles de la búsqueda
1.
Using the technology acceptance model to assess clinician perceptions and experiences with a rheumatoid arthritis outcomes dashboard: qualitative study.
BMC Med Inform Decis Mak
; 24(1): 140, 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38802865
2.
The association of trauma with self-reported flares and disease activity in systemic lupus erythematosus (SLE).
Rheumatology (Oxford)
; 62(8): 2780-2788, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36477308
3.
Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a Multiethnic Cohort of Patients With Systemic Lupus Erythematosus.
J Rheumatol
; 50(10): 1302-1309, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321640
4.
Does the Use of Immunosuppressive Drugs Impact on SARS-CoV-2 Infection Outcome? Data From A National Cohort of Patients With Immune-Mediated Inflammatory Diseases (SAR-COVID Registry).
J Clin Rheumatol
; 29(2): 68-77, 2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36454054
5.
Review of publications evaluating opioid use in patients with inflammatory rheumatic disease.
Curr Opin Rheumatol
; 34(2): 95-102, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35044328
6.
Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19.
Ann Intern Med
; 174(8): 1151-1158, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125574
7.
Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance.
Curr Opin Rheumatol
; 33(2): 111-116, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33394601
8.
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Ann Rheum Dis
; 80(7): 930-942, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504483
9.
The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice.
Rheumatology (Oxford)
; 60(1): 353-358, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32789449
10.
Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons - California, 2007-2017.
MMWR Morb Mortal Wkly Rep
; 70(7): 236-239, 2021 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33600382
11.
Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry.
Rheumatol Int
; 41(10): 1755-1761, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34338816
12.
Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases.
Curr Opin Rheumatol
; 32(5): 434-440, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32675715
13.
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Ann Rheum Dis
; 79(7): 859-866, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32471903
14.
Patient and clinician perspectives on a patient-facing dashboard that visualizes patient reported outcomes in rheumatoid arthritis.
Health Expect
; 23(4): 846-859, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32270591
15.
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial.
PLoS Med
; 16(5): e1002800, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31067237
16.
Quality improvement initiatives in rheumatology: an integrative review of the last 5 years.
Curr Opin Rheumatol
; 31(2): 98-108, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30608250
17.
Prevalence of clinically meaningful antiphospholipid antibodies in patients with systemic lupus erythematosus varies by race and ethnicity.
Ann Rheum Dis
; 83(3): 404-406, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875285
18.
Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry" by Sparks et al.
Ann Rheum Dis
; 82(7): e158, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34426400
19.
Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by van Vollenhoven et al.
Ann Rheum Dis
; 82(8): e178, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34389604
20.
Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum et al.
Ann Rheum Dis
; 82(6): e139, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33985941